Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 11,759,494
- Share change
- -2,153,010
- Total reported value
- $12,816,995
- Put/Call ratio
- 5.4%
- Price per share
- $1.09
- Number of holders
- 55
- Value change
- -$1,528,241
- Number of buys
- 27
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13F
|
Company |
12%
|
4,997,240
|
$3,783,910 | — | 30 Sep 2024 | |
| Michael J. Fox |
3/4/5
|
Director |
—
mixed-class rows
|
1,148,800
mixed-class rows
|
$3,036,000 | — | 05 Jun 2024 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| Slate Path Capital LP |
13F
13D/G
|
Company |
1.4%
from 13D/G
|
2,402,455
|
$1,819,139 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
2,031,421
|
$1,537,786 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.3%
|
570,975
|
$432,342 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
508,827
|
$385,370 | — | 30 Sep 2024 | |
| Anish Suri |
3/4/5
|
PRESIDENT AND CSO |
—
mixed-class rows
|
285,638
mixed-class rows
|
$374,361 | — | 05 Jun 2024 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$362,320 | — | 30 Sep 2024 | |
| Sigma Planning Corp |
13F
|
Company |
0.92%
|
401,325
|
$303,883 | — | 30 Sep 2024 | |
| Good Life Advisors, LLC |
13F
|
Company |
0.92%
|
400,000
|
$302,880 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.83%
|
358,974
|
$271,815 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.67%
|
291,663
|
$221,000 | — | 30 Sep 2024 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$194,771 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
239,202
|
$181,077 | — | 30 Sep 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.45%
|
194,222
|
$147,067 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.41%
|
177,053
|
$134,065 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
138,314
|
$104,731 | — | 30 Sep 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.19%
|
83,284
|
$64,000 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
74,175
|
$56,150 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
33,692
|
$25,512 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
27,665
|
$20,948 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
25,935
|
$19,638 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.06%
|
24,672
|
$18,682 | — | 30 Sep 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.06%
|
24,098
|
$18,247 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
20,077
|
$15,202 | — | 30 Sep 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
20,000
|
$15,000 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
18,563
|
$14,056 | — | 30 Sep 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
17,925
|
$13,573 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
14,575
|
$10,896 | — | 30 Sep 2024 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.03%
|
13,000
|
$9,844 | — | 30 Sep 2024 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$7,572 | — | 30 Sep 2024 | |
| Legacy Capital Group California, Inc. |
13F
|
Company |
0.02%
|
10,000
|
$7,572 | — | 30 Sep 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0.02%
|
9,000
|
$6,814 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
7,217
|
$5,463 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,029
|
$4,565 | — | 30 Sep 2024 | |
| Gleason Group, Inc. |
13F
|
Company |
0.01%
|
6,000
|
$4,543 | — | 30 Sep 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
4,056
|
$3,000 | — | 30 Sep 2024 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
3,000
|
$2,272 | — | 30 Sep 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.01%
|
2,550
|
$1,931 | — | 30 Sep 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.01%
|
2,500
|
$1,893 | — | 30 Sep 2024 | |
| Larson Financial Group LLC |
13F
|
Company |
0%
|
1,400
|
$1,060 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
904
|
$685 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
801
|
$606 | — | 30 Sep 2024 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
439
|
$332 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
380
|
$288 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
285
|
$216 | — | 30 Sep 2024 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
237
|
$179 | — | 30 Sep 2024 | |
| Arax Advisory Partners |
13F
|
Company |
0%
|
215
|
$163 | — | 30 Sep 2024 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2024
As of 31 Dec 2024,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,759,494 shares.
The largest 10 holders included
Bleichroeder LP, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Robertson Stephens Wealth Management, LLC, Sigma Planning Corp, Good Life Advisors, LLC, BANK OF AMERICA CORP /DE/, ADVISORY RESEARCH INC, and STIFEL FINANCIAL CORP.
This page lists
55
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
50
Q4 2024 holders
55
Holder diff
5
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.